Investor News

Get News Alerts by Email

  • Medicure Files Patent Infringement Action

    Friday, November 16, 2018

    View article

  • Medicure Q3 2018 Results and Conference Call Dates

    Wednesday, November 14, 2018

    View article

  • Medicure Reports Financial Results for Quarter Ended June 30, 2018

    Wednesday, August 15, 2018

    View article

  • Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

    Monday, August 13, 2018

    View article

  • Medicure Q2 2018 Results and Conference Call Dates

    Wednesday, August 8, 2018

    View article

  • Medicure Reports Financial Results for Quarter Ended March 31, 2018

    Wednesday, May 23, 2018

    View article

  • Medicure Q1 2018 Results and Conference Call Dates

    Thursday, May 17, 2018

    View article

  • Medicure Announces Normal Course Issuer Bid

    Thursday, May 17, 2018

    View article

  • Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017

    Tuesday, May 1, 2018

    View article

  • Medicure announces availability of ZYPITAMAG™ (pitavastatin) in the U.S.

    Tuesday, May 1, 2018

    View article

  • Medicure to Announce Fiscal Year End 2017 Financial Results on April 30, 2018

    Tuesday, April 24, 2018

    View article

  • Medicure Announces Further Up-Date on PREXXARTAN®

    Wednesday, March 28, 2018

    View article

  • Medicure Announces an Up-Date on PREXXARTAN® Launch

    Monday, March 19, 2018

    View article

  • Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.

    Wednesday, March 7, 2018

    View article

  • Medicure Announces Receipt of Deferred Proceeds from Apicore Sale

    Thursday, February 1, 2018

    View article

  • Medicure Announces FDA Approval Received for Prexxartan®

    Tuesday, December 19, 2017

    View article

  • Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.

    Thursday, December 14, 2017

    View article

  • Medicure Reports Financial Results for Quarter Ended September 30, 2017

    Tuesday, November 21, 2017

    View article

  • Medicure Announces Repayment of Outstanding Debt

    Friday, November 17, 2017

    View article

  • Medicure Q3 Results and Conference Call Dates

    Wednesday, November 15, 2017

    View article

  • Medicure Acquires Exclusive License to Sell and Market PREXXARTAN® in the U.S. from Carmel Biosciences

    Tuesday, October 31, 2017

    View article

  • Medicure Announces Sale of Apicore Business

    Tuesday, October 3, 2017

    View article

  • Medicure Reports Financial Results for Quarter Ended June 30, 2017

    Monday, August 7, 2017

    View article

  • Medicure Q2 Results and Conference Call Dates

    Wednesday, August 2, 2017

    View article

  • Medicure Closes Acquisition of Additional Interests in Apicore

    Wednesday, July 12, 2017

    View article

  • Medicure Exercises Option to Acquire Additional Interests in Apicore

    Monday, July 10, 2017

    View article

  • Medicure Provides Update on Apicore Purchase Option

    Monday, July 3, 2017

    View article

  • Medicure Reports Financial Results for Quarter Ended March 31, 2017

    Wednesday, May 24, 2017

    View article

  • Medicure Q1 Results and Conference Call Dates

    Thursday, May 18, 2017

    View article

  • Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016

    Wednesday, April 26, 2017

    View article

  • Medicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017

    Wednesday, March 29, 2017

    View article

  • Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine

    Thursday, March 23, 2017

    View article

  • Medicure Provides Apicore Secured Loan to Replace Knight Loan

    Monday, January 9, 2017

    View article

  • Medicure announces filing of ANDA in collaboration with Apicore

    Tuesday, December 13, 2016

    View article

  • Medicure Closes Acquisition of Majority Interest in Apicore

    Thursday, December 1, 2016

    View article

  • Medicure to Hold Investor Call on November 21, 2016

    Friday, November 18, 2016

    View article

  • Medicure Exercises Option to Acquire Majority Interest in Apicore

    Friday, November 18, 2016

    View article

  • Medicure Reports Third Quarter 2016 Financial Results

    Wednesday, November 9, 2016

    View article

  • Medicure to Announce Q3 2016 Financial Results on November 9, 2016

    Wednesday, November 2, 2016

    View article

  • FDA Approves New AGGRASTAT® Product Format

    Thursday, September 1, 2016

    View article

  • Medicure Reports Second Quarter 2016 Financial Results

    Wednesday, August 10, 2016

    View article

  • Medicure to Announce Q2 2016 Financial Results on August 10, 2016

    Wednesday, August 3, 2016

    View article

  • Medicure Receives Response Letter from FDA on AGGRASTAT® sNDA for New Indication

    Thursday, July 7, 2016

    View article

  • Medicure Reports First Quarter 2016 Financial Results

    Wednesday, May 11, 2016

    View article

  • Medicure Files Application for New AGGRASTAT® Product Format

    Wednesday, May 11, 2016

    View article

  • Medicure Announces Departure of President and Chief Operating Officer

    Monday, May 9, 2016

    View article

  • Medicure to Announce Q1 2016 Financial Results on May 11, 2016

    Wednesday, May 4, 2016

    View article

  • Medicure Announces Grant of Options

    Thursday, April 7, 2016

    View article

  • Medicure Announces Upcoming Conference Presentations

    Tuesday, April 5, 2016

    View article

  • Medicure Reports Financial Results for Quarter and Year Ended December 31, 2015

    Wednesday, March 30, 2016

    View article